Found: 22
Select item for more details and to access through your institution.
Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 6, p. 1605, doi. 10.1007/s40121-023-00806-0
- By:
- Publication type:
- Article
Antigen presentation by B cells guides programing of memory CD4<sup>+</sup> T-cell responses to a TLR4-agonist containing vaccine in mice.
- Published in:
- European Journal of Immunology, 2016, v. 46, n. 12, p. 2719, doi. 10.1002/eji.201646399
- By:
- Publication type:
- Article
Preparation Strategies of the Anti-Mycobacterial Drug Bedaquiline for Intrapulmonary Routes of Administration.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 5, p. 729, doi. 10.3390/ph16050729
- By:
- Publication type:
- Article
An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis.
- Published in:
- Vaccines, 2023, v. 11, n. 1, p. 130, doi. 10.3390/vaccines11010130
- By:
- Publication type:
- Article
Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment.
- Published in:
- Vaccines, 2018, v. 6, n. 2, p. 30, doi. 10.3390/vaccines6020030
- By:
- Publication type:
- Article
It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.840225
- By:
- Publication type:
- Article
A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines.
- Published in:
- Scientific Reports, 2017, p. 46426, doi. 10.1038/srep46426
- By:
- Publication type:
- Article
Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.935444
- By:
- Publication type:
- Article
Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00295
- By:
- Publication type:
- Article
Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0016333
- By:
- Publication type:
- Article
A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines.
- Published in:
- PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013677
- By:
- Publication type:
- Article
Therapeutic Immunization against Mycobacterium tuberculosis Is an Effective Adjunct to Antibiotic Treatment.
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 8, p. 1242, doi. 10.1093/infdis/jis425
- By:
- Publication type:
- Article
The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases.
- Published in:
- PLoS Neglected Tropical Diseases, 2019, v. 13, n. 2, p. 1, doi. 10.1371/journal.pntd.0007083
- By:
- Publication type:
- Article
Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.
- Published in:
- PLoS ONE, 2021, v. 16, n. 3, p. 1, doi. 10.1371/journal.pone.0247990
- By:
- Publication type:
- Article
Mycobacterium abscessus : It's Complex.
- Published in:
- Microorganisms, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/microorganisms10071454
- By:
- Publication type:
- Article
Long-term protective efficacy with a BCG-prime ID93/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-52146-0
- By:
- Publication type:
- Article
Subunit vaccine protects against a clinical isolate of Mycobacterium avium in wild type and immunocompromised mouse models.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-88291-8
- By:
- Publication type:
- Article
A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis.
- Published in:
- Science Translational Medicine, 2010, v. 2, n. 53, p. 1, doi. 10.1126/scitranslmed.3001094
- By:
- Publication type:
- Article
Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy.
- Published in:
- Influenza & Other Respiratory Viruses, 2013, v. 7, n. 5, p. 815, doi. 10.1111/irv.12031
- By:
- Publication type:
- Article
SARS-CoV-2 infection and immune responses.
- Published in:
- AIMS Microbiology, 2023, v. 9, n. 2, p. 245, doi. 10.3934/microbiol.2023015
- By:
- Publication type:
- Article
Antibodies as key mediators of protection against Mycobacterium tuberculosis.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1430955
- By:
- Publication type:
- Article
Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1424374
- By:
- Publication type:
- Article